The Cancer Genome Atlas (TCGA) microRNA (miRNA) initiative has revealed a pivotal role for miRNAs in cancer. (1)

ROCHESTER, NEW YORK, UNITED STATES OF AMERICA, September 18, 2015 /EINPresswire.com/ --

“Infected with the EBV virus? We recommend taking Gene-Eden-VIR or Novirin.” – Greg Bennett, CBCD

Most people associate the Epstein Barr Virus (EBV) with infectious mononucleosis (Mono, also known as “the kissing disease”). However, science is showing that EBV is also linked to many different forms of cancer. This is significant since most people are infected with this virus. Now, new research has shown that “a particular cluster of EBV-miRNA (miR-BART2, miR-BART4, miR-BART5, miR-BART18, and miR-BART22) is associated with expression of cytokines known to inhibit host response to cancer.” (1) This means that particular proteins made by the Epstein-Barr Virus are associated with other proteins (cytokines) that keep the immune system from attacking cancer cells. Even more importantly, Dr. Pandya, the lead researcher in the study, showed that infected individuals who had cancer faced a worse outcome than uninfected individuals.

The Center for the Biology of Chronic Disease (CBCD) recommends that EBV infected individuals take Gene-Eden-VIR or Novirin against the latent form of the virus. The formula of these natural antiviral products was shown to reduce symptoms of EBV infection in two separate post-marketing clinical studies that followed FDA guidelines.

Click to learn more about EBV symptoms.

The formula of these natural antiviral products was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the Gene-Eden-VIR and Novirin formula is effective against HSV and other viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, “individuals infected with EBV…reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR.” (2) The study authors also wrote that, “We observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (2) In addition, this natural antiviral was recently proven to reduce mental and physical fatigue in a post-marketing clinical study that followed FDA guidelines.

Both products can be ordered online on the Gene-Eden-VIR and Novirin websites, here:

http://www.gene-eden-vir.com

and

http://www.novirin.com

Gene-Eden-VIR and Novirin are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Novirin and Gene-Eden-VIR are the only natural antiviral products on the market with published clinical studies that support their claims.

Dr. Martinez-Lopez wrote in another study that “Epstein-Barr Virus (EBV) infection has been associated with several types of lymphoma and nasopharyngeal carcinoma (NPC).” (3) In other words, EBV is linked to many forms of cancer.

EBV chronically infects about 95% of the adult population, with virus usually present in B cells in a latent stage. (3) However, not everyone infected will develop cancer. According to Dr. Polansky, and his book “Microcompetition with Foreign DNA and the Origin of Chronic Disease,” people develop cancer when the number of latent viruses passes a certain threshold. One of the reasons for an increase in the number of latent viruses is a weak immune system.

The CBCD offers a free download of Dr. Polansky’s book to those who are interested in reading it.

http://www.cbcd.net/Book.php

Dr. Fujiwara wrote that people with a chronic EBV infection face a poor outcome. In addition to constant symptoms of Mononucleosis, they can also develop “life-threatening complications including hemophagocytic lymphohistiocytosis (a condition that causes the immune system to attack the body’s own tissues), organ failure, and malignant lymphomas (cancer).” (4) Dr. Fujiwara is from the Department of Infectious Diseases, National Research Institute for Child Health and Development in Tokyo, Japan.

What standard treatments are available for EBV infections?

“A few antiviral drugs are available that were shown to inhibit EBV replication in cell culture. These drugs include the acyclic nucleoside analogues aciclovir, ganciclovir, penciclovir, and their respective prodrugs valaciclovir, valganciclovir and famciclovir, the acyclic nucleotide analogues cidofovir and adefovir, and the pyrophosphate analogue foscarnet. However, clinical studies have shown that these drugs are mostly ineffective in humans.” (2) There are also natural antiviral products that studies show to be safe and effective in reducing EBV symptoms. Two of these products are Gene-Eden-VIR and Novirin.

In light of the above information, the CBCD recommends that individuals infected with the Epstein Barr Virus (EBV) take Gene-Eden-VIR or Novirin.

Find us on Facebook here: https://www.facebook.com/GeneEdenVIR
Follow us on Twitter here: @HananPolansky

References:

(1) Pandya D1, Mariani M1, He S1, Andreoli M1, Spennato M1, Dowell-Martino C1, Fiedler P1, Ferlini C1. "Epstein-Barr Virus MicroRNA Expression Increases Aggressiveness of Solid Malignancies." PLoS One. 2015 Sep 16;10(9):e0136058
(2) Polansky H, Itzkovitz E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Pharmacology & Pharmacy, 2013, 4, 1-8 http://dx.doi.org/10.4236/pp.2013.46A001
(3) Juan L.E. Martínez-López 1,2email, Javier Torres 3email, Margarita Camorlinga-Ponce 3email, Alejandra Mantilla 4email, Yelda A. Leal 5email and Ezequiel M. Fuentes-Pananá 1Evidence of Epstein-Barr Virus Association with Gastric Cancer and Non-Atrophic Gastritis Viruses2014, 6(1), 301-318
(4) Fujiwara S1, Kimura H, Imadome K, Arai A, Kodama E, Morio T, Shimizu N, Wakiguchi H. Current research on chronic active Epstein-Barr virus infection in Japan. Pediatr Int. 2014 Apr;56 (2):159-66.

Greg Bennett
CBCD
585-250-9999
email us here